Resverlogix (RVX) Competitors C$0.04 +0.01 (+14.29%) As of 01:01 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsInsider TradesBuy This Stock RVX vs. IBT, GSD, AEZS, LTY, ACST, REUN, BCT, NEPT, ATE, and SBMShould you be buying Resverlogix stock or one of its competitors? The main competitors of Resverlogix include IBEX Technologies (IBT), Devonian Health Group (GSD), Aeterna Zentaris (AEZS), Liberty Biopharma (LTY), Acasti Pharma (ACST), Reunion Neuroscience (REUN), BriaCell Therapeutics (BCT), Neptune Wellness Solutions (NEPT), Antibe Therapeutics (ATE), and Sirona Biochem (SBM). These companies are all part of the "biotechnology" industry. Resverlogix vs. IBEX Technologies Devonian Health Group Aeterna Zentaris Liberty Biopharma Acasti Pharma Reunion Neuroscience BriaCell Therapeutics Neptune Wellness Solutions Antibe Therapeutics Sirona Biochem IBEX Technologies (CVE:IBT) and Resverlogix (TSE:RVX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their community ranking, valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment. Which has stronger earnings & valuation, IBT or RVX? IBEX Technologies has higher revenue and earnings than Resverlogix. Resverlogix is trading at a lower price-to-earnings ratio than IBEX Technologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIBEX TechnologiesC$5.77M6.15C$3.10MC$0.1211.52ResverlogixN/AN/A-C$2.81M-C$0.02-1.98 Is IBT or RVX more profitable? IBEX Technologies has a net margin of 53.78% compared to Resverlogix's net margin of 0.00%. IBEX Technologies' return on equity of 21.95% beat Resverlogix's return on equity.Company Net Margins Return on Equity Return on Assets IBEX Technologies53.78% 21.95% 6.42% Resverlogix N/A 6.06%-34.90% Does the MarketBeat Community favor IBT or RVX? Resverlogix received 275 more outperform votes than IBEX Technologies when rated by MarketBeat users. Likewise, 84.01% of users gave Resverlogix an outperform vote while only 57.38% of users gave IBEX Technologies an outperform vote. CompanyUnderperformOutperformIBEX TechnologiesOutperform Votes3557.38% Underperform Votes2642.62% ResverlogixOutperform Votes31084.01% Underperform Votes5915.99% Do insiders & institutionals hold more shares of IBT or RVX? 19.1% of IBEX Technologies shares are held by institutional investors. 25.4% of IBEX Technologies shares are held by company insiders. Comparatively, 42.7% of Resverlogix shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Which has more volatility and risk, IBT or RVX? IBEX Technologies has a beta of -0.05, indicating that its share price is 105% less volatile than the S&P 500. Comparatively, Resverlogix has a beta of 0.71, indicating that its share price is 29% less volatile than the S&P 500. Does the media prefer IBT or RVX? In the previous week, IBEX Technologies' average media sentiment score of 0.00 equaled Resverlogix'saverage media sentiment score. Company Overall Sentiment IBEX Technologies Neutral Resverlogix Neutral SummaryIBEX Technologies beats Resverlogix on 8 of the 12 factors compared between the two stocks. Get Resverlogix News Delivered to You Automatically Sign up to receive the latest news and ratings for RVX and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RVX vs. The Competition Export to ExcelMetricResverlogixBiotechnology IndustryMedical SectorTSE ExchangeMarket CapC$7.92MC$120.47MC$5.40BC$5.63BDividend Yield7.02%3.69%5.44%6.83%P/E Ratio-1.983.0022.2130.05Price / SalesN/A4,171.19392.73599.62Price / Cash132.5013.0238.2083.07Price / Book-0.1734.396.773.73Net Income-C$2.81M-C$90.45MC$3.21BC$300.28M7 Day PerformanceN/A1.24%4.85%2.32%1 Month PerformanceN/A-4.02%-6.31%-2.16%1 Year PerformanceN/A89.57%16.24%13.33% Resverlogix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RVXResverlogixN/AC$0.04+14.3%N/A-33.3%C$7.92MN/A-1.9819Gap UpIBTIBEX TechnologiesN/AC$1.44flatN/A+0.0%C$35.54MC$5.77M11.52N/AGSDDevonian Health GroupN/AC$0.18-18.2%N/A-18.2%C$26.68MC$9.75M-9.006Gap DownAEZSAeterna ZentarisN/AN/AN/AN/AC$25.37MC$2.37M-2.6120LTYLiberty BiopharmaN/AC$2.00+∞N/A+0.0%C$21.54MN/A-12.66N/AGap UpACSTAcasti PharmaN/AC$0.58+1.8%N/A+0.0%C$18.19MC$2.71M-1.2132REUNReunion NeuroscienceN/AN/AN/AN/AC$16.64MC$4.86M-0.43190Gap DownBCTBriaCell TherapeuticsN/AC$6.17+16.0%N/A+142.5%C$15.91MN/A-4.6616News CoverageNegative NewsGap UpHigh Trading VolumeNEPTNeptune Wellness SolutionsN/AN/AN/AN/AC$15.73MC$48.80M-0.08130Gap DownATEAntibe TherapeuticsN/AN/AN/AN/AC$15.64MC$9.71M-0.8411SBMSirona BiochemN/AC$0.06-7.7%N/A-7.7%C$15.41MC$683,768.00-6.00N/AGap DownHigh Trading Volume Related Companies and Tools Related Companies IBEX Technologies Competitors Devonian Health Group Competitors Aeterna Zentaris Competitors Liberty Biopharma Competitors Acasti Pharma Competitors Reunion Neuroscience Competitors BriaCell Therapeutics Competitors Neptune Wellness Solutions Competitors Antibe Therapeutics Competitors Sirona Biochem Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:RVX) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Resverlogix Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Resverlogix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RVX Stock Free RVX Stock Alerts